v3.19.3.a.u2
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 5,108,407 4,669,747
Sales and marketing 189,394 304,601
Depreciation and amortization expense 216,737 120,488
General and administrative expenses 7,428,850 3,107,813
Total operating expenses 12,943,388 8,202,649
Loss from operations (12,943,388) (8,202,649)
Other (expense) income:    
Interest expense (822,858) (1,115,501)
Other income 14,369 3,214
Total other expense (808,489) (1,112,287)
Loss before income taxes (13,751,877) (9,314,936)
Income tax expense 0 0
Net loss 13,751,877 9,314,936
Accrued dividends to Series A and Series B preferred stockholders (160,219) (1,280,000)
Net loss attributable to common stockholders $ (13,912,096) $ (10,594,936)
Net loss per common share, basic and diluted $ (1.00) $ (5.64)
Weighted average number of common shares outstanding, basic and diluted 13,841,884 1,877,775

Source